This pathogen is very common in Latin America, responsible for 22% of BSI isolates but, according to the ARTEMIS DISK Global Antifungal Surveillance Study, its incidence worldwide has reached 4%–7% with an increasing trend. 18 C. krusei is another important pathogen among patients with hematologic malignancies, and among blood marrow transplant recipients, characterized by intrinsic resistance to fluconazole. 1 C. krusei accounts for 2%–5% of all Candida infections worldwide, having emerged in oncology patients u
1
—
—